# Memantine in Bipolar Patients With Alcoholism

> **NCT03043001** · PHASE3 · UNKNOWN · sponsor: **National Cheng-Kung University Hospital** · enrollment: 60 (estimated)

## Conditions studied

- AOD Effects and Consequences

## Interventions

- **DRUG:** Memantine

## Key facts

- **NCT ID:** NCT03043001
- **Lead sponsor:** National Cheng-Kung University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01-01
- **Primary completion:** 2016-12-31
- **Final completion:** 2017-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2017-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03043001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03043001, "Memantine in Bipolar Patients With Alcoholism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03043001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*